נוקדירנה 25 - Noqdirna 25
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | H01BA Vasopressin and analogues |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ×ת×ת ××ש×× - SUBLINGUAL |
| צ×רת ××× ×× | ×××××ת ×ס×ס×ת, TABLETS SOLUBLE ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | NOCDURNA is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void.In the NOCDURNA clinical trials nocturnal polyuria was defined as night-time urine production exceeding one-third of the 24-hour urine production. Before starting NOCDURNA:â¢Evaluate the patient for possible causes for the nocturia, including excessive fluid intake prior to bedtime, and address other treatable causes of nocturia.â¢Confirm the diagnosis of nocturnal polyuria with a 24-hour urine collection, if one has not been obtained previously. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| × ××§×××¨× × 25 ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | FERRING GmbH ,GERMANY |
| ×©× ××¢× ×ר×ש×× | FERRING PHARMACEUTICALS LTD |
| ר×ש××× | ת×ר×× ××ש×: 2/2017. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | {{{ת×ר×× ×¢××××}}} |
השינוי האחרון נעשה בֹ־7 באפריל 2023 ב־11:34